Biotoxtech Co., Ltd. (KOSDAQ:086040)
3,355.00
+105.00 (3.23%)
At close: Apr 24, 2026
Biotoxtech Revenue
In the year 2025, Biotoxtech had annual revenue of 47.02B KRW with 13.73% growth. Biotoxtech had revenue of 14.25B in the quarter ending December 31, 2025, with 24.75% growth.
Revenue
47.02B
Revenue Growth
+13.73%
P/S Ratio
1.12
Revenue / Employee
250.09M
Employees
188
Market Cap
52.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.02B | 5.68B | 13.73% |
| Dec 31, 2024 | 41.34B | 8.71B | 26.69% |
| Dec 31, 2023 | 32.63B | -4.66B | -12.50% |
| Dec 31, 2022 | 37.29B | 4.57B | 13.98% |
| Dec 31, 2021 | 32.72B | 6.29B | 23.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Omnisystem | 99.07B |
| Carelabs Co.,Ltd | 81.69B |
| Bankware Global | 63.45B |
| WOOJUNG BIO | 37.59B |
| The Cube & | 24.91B |
| Moadata | 23.17B |
| RN2 Technologies | 18.65B |
| GFC Life Science | 17.71B |